Summary by Futu AI
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (AND PLATINUM PHARMACEUTICS-B) ISSUED A NOTICE TO SHAREHOLDERS ON 26 APRIL 2024 TO ANNOUNCE THAT THE CHINESE AND ENGLISH VERSIONS OF ITS 2023 ANNUAL REPORT, CIRCULAR, NOMINATION FORM AND NOTICE OF ANNUAL GENERAL MEETING (THIS COMPANY NEWSLETTER) ARE AVAILABLE ON THE COMPANY'S WEBSITE AND ON THE HKEX LIMITED WEBSITE. THE COMPANY ENCOURAGES SHAREHOLDERS TO READ THIS AND FUTURE CORPORATE NEWSLETTERS VIA THE WEBSITE. For shareholders who choose to receive printed company communications, the company will provide printed copies. In addition, the company reminds shareholders of the obligation to provide a valid email address and update it when necessary. If the shareholder fails to provide a valid email address, the Company will only be able to send the communication in printed form. Shareholders may choose to receive a printed or electronic newsletter by filling in the return form. The Company's Share Transfer Registry Branch, Zhujia Securities Registration Limited, will handle the matter.